VP of Scientific Engagement
Metrum Research Group
Tariffville, Connecticut, United States
Stacey Tannenbaum, PhD, FISoP is the Vice President of Scientific Engagement at Metrum Research Group. Prior to joining MetrumRG, she had 20 years of Modeling and Simulation experience in Pharma, first at Novartis and then Astellas; during her last 5 years at Astellas she was the lead of the US Pharmacometrics group. Stacey completed her BSE in Biomedical Engineering at Duke University, and her PhD in Pharmaceutical Sciences and Applied Mathematics at the University of Arizona, followed by a post-doctoral fellowship at the Center for Drug Development Science at Georgetown University. She holds faculty positions at the University of Arizona, University of the Pacific, and the University of Tennessee Health Science Center.
Stacey has had significant impact on the global Pharmacometrics community by co-founding the International Society of Pharmacometrics (ISoP), serving as its first President, and sits on a number of ISoP committees and interest groups including leadership on the Statistics and Pharmacometrics (SxP) SIG. She received the ISoP Fellowship in 2014 and Leadership Award in 2018. Stacey co-founded the American Conference on Pharmacometrics (ACoP) and was conference chair for the first three events. She was a co-founder of the local networking group Modeling and Simulation Applications in Clinical Pharmacotherapy (MoSAiC) and is the Executive Committee chair for the World Conference on Pharmacometrics (WCoP). She served as a board member of the American Association of Pharmaceutical Scientists (AAPS), chaired the AAPS M&S Focus Group, and was the co-chair for the AAPS Forum for Connecting Predictive Modelers. She is the vice chair of the Quantitative Pharmacology Network at the American Society of Clinical Pharmacology and Therapeutics (ASCPT).
Disclosure(s): No financial relationships to disclose
Is Pharmacometrics limited by the industry settings?
Wednesday, November 13, 2024
1:45 PM – 3:15 PM MST